Juuso Juhila

Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers

Tuuli Ranki, Sari Pesonen, Akseli Hemminki et al. · Journal for ImmunoTherapy of Cancer · 2016 · 202 citations · Full text

Pharmacy, Immunology, Oncology +17

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

Otto Hemminki, Suvi Parviainen, Juuso Juhila et al. · Oncotarget · 2015 · 87 citations · Full text

Life Sciences, Immunology, Oncology +12

Circadian Timekeeping Is Disturbed in Rheumatoid Arthritis at Molecular Level

Vesa‐Petteri Kouri, Juri Olkkonen, Emilia Kaivosoja et al. · PLoS ONE · 2013 · 86 citations · Full text

Medicine, Immunology, Molecular Biology +17

MicroRNA Expression Profiling Reveals MiRNA Families Regulating Specific Biological Pathways in Mouse Frontal Cortex and Hippocampus

Juuso Juhila, Tessa Sipilä, Katherine Icay et al. · PLoS ONE · 2011 · 78 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +14

 -Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys

Elina Heikkilä, Juuso Juhila, Markus Lassila et al. · Nephrology Dialysis Transplantation · 2010 · 62 citations

Medicine, Cell Biology, Nephrology +17